Gregory Gene Freitag, Director at PDS Biotechnology Corp (PDSB), bought 15,060 shares at $1.66 ($25K) on 2025-02-28, disclosed to the SEC on 2025-03-03.
Open-market purchase of $25k PDSB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| AXGN | SELL | 2023-05-24 | $69K | — | Filing → |
| AXGN | SELL | 2022-11-16 | $166K | — | Filing → |
| AXGN | SELL | 2022-11-10 | $163K | — | Filing → |